The biotechnology industry touches every part of our lives, from the medicines helping patients, the food we eat, and the fuels that power our transportation system to novel ways to produce plastics and industrial inputs historically derived from petroleum. This panel is a collection of industry advisors and ESG experts that will share their view of how the biotechnology industry is positioned to make differentiated and meaningful contributions to the ESG challenges faced by the world. This forward looking discussion will touch on the power of partnerships, the unique challenges that can only be solved by biotech and where the needle moving opportunities lie.